Global Multiple Sclerosis - Drug Pipeline Market Prospects
Multiple Sclerosis - Drug Pipeline Analysis and Market Forecasts to 2015
The report is an essential source of information and analysis on the global multiple sclerosis (MS) market. The report identifies the key trends shaping and driving the global MS market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to cause significant shifts in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global MS sector. ( http://www.bharatbook.com/detail.asp?id=128435&rt=Multiple-Sclerosis-Drug-Pipeline-Analysis-and-Market-Forecasts-to-2015.html )
The scope of the report includes:
- Annualized global multiple sclerosis market revenues data from 2000 to 2008, forecast forward for 7 years to 2015.
- Geographies covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
- Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends. Key classes of mechanism of action include immunomodulator and anti-inflammatory, cytokine and cytokine-receptor targetters, ion channel targetters, metabolic pathway''s enzymes targetters, remyelination stimulator and demyelination inhibitor, and neurotransmitters targetters.
- Analysis of the current and future market competition in the global multiple sclerosis market. Key market players covered are Biogen idec, Merck Serono, Sanofi Aventis, AstraZeneca and Glenmark Pharmaceuticals Ltd.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with multiple sclerosis.
Reasons to buy
The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global multiple sclerosis market.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global multiple sclerosis market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- Whats the next big thing in the global multiple sclerosis market landscape? Identify, understand and capitalize.
To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/detail.asp?id=128435&rt=Multiple-Sclerosis-Drug-Pipeline-Analysis-and-Market-Forecasts-to-2015.html
Contact us at :
Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Follow us on twitter: http://twitter.com/3bbharatbook
by: bharat book bureauAbout the Author:Bharat Book Bureau facilitates companies to take the lead of their industry with best practice business strategies and intelligence, through a unique combination of published reports, databases, country reports, company profiles and customized research services. Bharat Book Bureau provides strategic information tools to the executives, business analysts, and knowledge managers that will help them to probe into and support critical, timely business decisions and strategies.